Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Syddansk Universitet Forside
Hjælp og FAQ
Dansk
English
Forside
Forskere
Forskningsenheder
Publikationer
Aktiviteter
Projekter
Datasæt
Presse/medie
Priser
Undervisning
Impacts
Søg efter ekspertise, navn eller tilknytning
Vis Scopus-profil
Peter Aaby
Klinisk Institut
Professor
,
KI, OUH, Forskningsenhed for Open - Bandim
https://orcid.org/0000-0001-8331-1389
E-mail
paaby
health.sdu
dk
Oversigt
Fingeraftryk
Netværk
Publikationer
(326)
Aktiviteter
(10)
Projekter
(2)
Presse/medie
(34)
Lignende forskere
(9)
Ph.d.-vejledning
(3)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Peter Aaby er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
5%
All Cause Mortality
24%
Asthma
5%
Atopy
7%
BCG Vaccine
19%
Case Fatality Rate
8%
Child Death
5%
Childhood Mortality
46%
Chloroquine
11%
Cluster Randomized Trial
9%
Cohort Study
23%
Cytokine
8%
Diarrhea
11%
Diphtheria
39%
Diphtheria Pertussis Poliomyelitis Tetanus Vaccine
5%
Diphtheria Pertussis Tetanus Vaccine
26%
Diseases
33%
Haemophilus Influenzae Type B
5%
Human Respiratory Syncytial Virus
9%
Inactivated Vaccine
5%
Infant Mortality
16%
Infection
56%
Infectious Agent
6%
Live Vaccine
17%
Low Birth Weight
10%
Measles
82%
Measles Antibody
7%
Measles Vaccine
100%
Mortality Rate
46%
Mumps
7%
Mycobacterium Bovis BCG
48%
Observational Study
33%
Oral Poliomyelitis Vaccine
62%
Overall Survival
5%
Pandemic
8%
Parasitemia
5%
Pertussis
39%
Placebo
13%
Plasmodium falciparum
6%
Prevalence
27%
Randomized Clinical Trial
17%
Randomized Controlled Trial
52%
Respiratory Tract Infection
5%
Retinol
45%
Rubella
7%
Scar Formation
15%
Smallpox
7%
Smallpox Vaccine
9%
Tetanus
39%
Tuberculin
12%
Medicine and Dentistry
All Cause Mortality
11%
Arm
10%
Atopy
7%
BCG Vaccination
24%
BCG Vaccine
18%
Birth Weight
9%
Childhood Mortality
41%
Cluster Randomized Trial
16%
Cohort Analysis
21%
Cytokine Response
8%
Diarrhea
17%
Diphtheria
29%
Diphtheria Pertussis Tetanus Vaccine
19%
Diseases
30%
Hazard Ratio
15%
Household
9%
Human Immunodeficiency Virus
23%
In Vitro
11%
Infant Mortality
18%
Infection
41%
Live Vaccine
12%
Low Birth Weight
26%
Measles
25%
Measles Vaccination
28%
Measles Vaccine
45%
Meta-Analysis
10%
Mortality Rate
31%
Mycobacterium Bovis BCG
36%
Neonatal Infant
17%
Neonate
9%
Newborn Mortality
8%
Nutritional Status
8%
Observational Study
11%
Oral Poliomyelitis Vaccine
48%
Pediatrics
7%
Pertussis
29%
Placebo
12%
Prevalence
12%
Proportional Hazards Model
13%
Randomized Clinical Trial
18%
Randomized Controlled Trial
25%
Respiratory Tract Infection
8%
Retinol
48%
Salmonella
10%
Smallpox Vaccine
8%
Supplementation
47%
Surveillance System
13%
Tetanus
29%
Typhoid Fever
9%
Vaccination Coverage
13%
Immunology and Microbiology
All Cause Mortality
6%
Atopy
5%
Attenuated Vaccine
5%
BCG Vaccine
12%
Booster Dose
5%
Childhood Mortality
23%
Cryptosporidium
8%
Cytokine
9%
Cytokine Production
15%
Cytokine Response
16%
DPT Vaccine
7%
Drug Megadose
9%
Human Immunodeficiency Virus
5%
Human Immunodeficiency Virus 1
9%
Human Respiratory Syncytial Virus
7%
Immune Response
15%
Immune System
5%
Infancy
5%
Infectious Agent
15%
Innate Immune System
9%
Interleukin 10
5%
Leukocyte
6%
Live Vaccine
5%
Low Birth Weight
9%
Maternal Antibody
6%
Measles
37%
Measles Antibody
17%
Measles Vaccine
50%
Mortality Rate
18%
Mycobacterium Bovis BCG
27%
Newborn Mortality
7%
Oral Poliomyelitis Vaccine
15%
Parasitemia
5%
Prevalence
30%
Salmonella
7%
Scar Formation
11%
Smallpox Vaccine
10%
Titer
8%
Tuberculin
9%
Tumor Necrosis Factor
9%
